Richard Wilk, MD
Sports Medicine · Boston, MANPI 1598864449
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $7,760 of the $10,558 with a category attached, or 73.5%. 7 manufacturers reported payments, led by Heron Therapeutics, Inc. at 45.3% of the total.
Across 18 payments — averaging $586.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Heron Therapeutics, Inc.$5K
- Pacira Pharmaceuticals Incorporated$4K
- Kairos Surgical Inc$1K
- Stryker$228
- Miach Orthopaedics, Inc.$180
- Zimmer Biomet$70
- plus $56 from 1 others
What the payments were for
- Consulting fees$7,76073%
- Travel & lodging$6226%
- Food & beverage$9779%
- Education$1,20011%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Heron Therapeutics, Inc. | 5 | $4,782 |
| Pacira Pharmaceuticals Incorporated | 4 | $4,028 |
| Kairos Surgical Inc | 2 | $1,214 |
| Stryker | 3 | $228 |
| Miach Orthopaedics, Inc. | 1 | $180 |
| Zimmer Biomet | 1 | $70 |
| Smith+Nephew | 2 | $56 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,558 in reported general payments places this provider in the 75th percentile of 138 sports medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Etodolac | 33 | $939 |
| Diclofenac Sodium | 17 | $196 |
| Meloxicam | 47 | $176 |
| Ibuprofen | 37 | $162 |
| Gabapentin | 11 | $124 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Boston
- Elizabeth MatzkinBoston$182K
- Xinning LiBoston$109K
- Miho TanakaBoston$89K
- Giovanna Ignacio Subira MedinaBoston$55K
- Elise BixbyBoston$53K
- Yi Meng YenBoston$52K
- James SatalichBoston$46K
- Evan OdonnellBoston$39K
- Ian HutchinsonBoston$39K
- Thomas HolovacsBoston$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.